肿瘤防治研究2024,Vol.51Issue(3) :157-162.DOI:10.3971/j.issn.1000-8578.2024.23.1237

循环肿瘤DNA在结直肠癌精准诊疗中的应用

Application of Circulating Tumor DNA in Precision Diagnosis and Treatment of Colorectal Cancer

杨文涛 李溟涵 蔡继东 李聪 宋望 徐烨
肿瘤防治研究2024,Vol.51Issue(3) :157-162.DOI:10.3971/j.issn.1000-8578.2024.23.1237

循环肿瘤DNA在结直肠癌精准诊疗中的应用

Application of Circulating Tumor DNA in Precision Diagnosis and Treatment of Colorectal Cancer

杨文涛 1李溟涵 1蔡继东 2李聪 1宋望 1徐烨1
扫码查看

作者信息

  • 1. 200032 上海,复旦大学附属肿瘤医院大肠外科,复旦大学上海医学院肿瘤学系
  • 2. 200032 上海,复旦大学附属肿瘤医院内镜科,复旦大学上海医学院肿瘤学系
  • 折叠

摘要

结直肠癌(colorectal cancer,CRC)是世界上最常见的恶性肿瘤之一,其发病率和死亡率居高不下,严重危害着人们的身体健康.传统的诊断模式已不能满足现如今人们对于肿瘤进行实时监测的需求.对比传统的检测手段,ctDNA检测不仅无创,而且能够实时检测肿瘤全面的基因组信息.随着检测技术的进步,逐渐凸显出其在CRC临床治疗中的潜在价值.本文就ctDNA在CRC患者中早期筛查、微小残留病变检测、指导个体化治疗的临床应用进展进行综述.

Abstract

Colorectal cancer(CRC)is one of the most common malignant tumors recorded worldwide.This condition has high morbidity and mortality and seriously endangers people's health.Traditional diagnostic models fail to meet people's current needs for real-time monitoring of tumors.Compared with traditional detection methods,ctDNA detection is not only noninvasive but can also attain real-time detection of comprehensive genomic information of tumors.The advancement of detection technology has gradually highlighted the potential of ctDNA detection in the clinical treatment of CRC.This article reviews the advancements on the clinical application of ctDNA in early screening,minimal residual disease detection,and guidance on individualized treatment of CRC patients.

关键词

结直肠癌/循环肿瘤DNA/精准治疗/筛查/疗效评估/耐药/肿瘤复发/预后

Key words

Colorectal cancer/Circulating tumor DNA/Precise treatment/Screening/Treatment efficacy evaluation/Drug resistance/Tumor recurrence/Prognosis

引用本文复制引用

出版年

2024
肿瘤防治研究
湖北省卫生厅,中国抗癌协会,湖北省肿瘤医院

肿瘤防治研究

CSTPCD
影响因子:0.737
ISSN:1000-8578
参考文献量61
段落导航相关论文